SF3B1 and myelodysplastic syndrome: Even though reports have shown that mutations in SF3B1 can lead to widespread changes in splicing (Inoue and Abdel-Wahab, 2016), the exact pathways that are disrupted and lead to the pathogenesis of ineffective hematopoiesis and carcinogenesis in MDS and AML are not yet fully elucidated.